| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 49.9 | 40.1 | 33.4 |
| Other income | 0.1 | 0.1 | 0.1 |
| Total income | 50.0 | 40.2 | 33.5 |
| Profit before exceptional items & tax | 8.0 | 3.2 | 3.7 |
| Profit before tax | 8.0 | 3.2 | 3.7 |
| Net profit | 5.9 | 2.4 | 2.8 |
| Operating margin | 16.0% | 8.0% | 11.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +110.70% |
|---|---|
| Net profit, quarter on quarter | +145.80% |
| Revenue, year on year | +49.40% |
NSE results filing, NSE: RNPL. Figures extracted from the filing.
Renol Polychem Ltd: key numbers
- Share price
- ₹79.70
- Market cap
- ₹96.31 Cr
- Revenue (annual)
- ₹89.99 Cr
- Net profit (annual)
- ₹8.25 Cr
- P/E (TTM)
- 11.7×Sector 36.8×
- Promoter holding
- 51.10%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Renol Polychem Ltd
All →Renol Polychem Other Announcement
Renol Polychem Limited has appointed H Togadiya & Associates as Secretarial Auditor, N. B. Sakhara & Co. as Internal Auditor, and Sunit M Chhatbar & Co. as Statutory Auditor.
Renol Polychem Board Meeting Outcome
Renol Polychem Limited announced the outcome of its board meeting held on September 07, 2026, approving the AGM notice and various auditor appointments for upcoming years.
Renol Polychem Annual General Meeting
Renol Polychem Limited has issued a notice for its 3rd Annual General Meeting, scheduled for September 30, 2026. Shareholders will consider various routine and special business items.
Renol Polychem Financial Results
Renol Polychem Limited reported its audited consolidated financial results for the year ended March 31, 2026. The board also reviewed statutory auditor reports and fund utilization statements.
Renol Polychem Board Meeting Date
Renol Polychem scheduled a board meeting for May 29, 2026, to approve audited annual financial results. The trading window remains closed until May 31.
Renol Polychem Other Announcement
Renol Polychem Limited informed the exchange that the requirement to submit an Annual Secretarial Compliance Report for FY2026 is not applicable. As an entity listed on the NSE EMERGE SME platform, the company is exempt from certain SEBI LODR regulations. This is a routine regulatory clarification for investors.